Mark A. Miller

26.7k citations
252 papers · 17.2k · 5 hit papers · h-index 66

Impact in

Papers in

    • Influenza Virus Research Studies 47
    • Respiratory viral infections research 13
    • Clostridium difficile and Clostridium perfringens research 45
    • Antimicrobial Resistance in Staphylococcus 13
    • Viral gastroenteritis research and epidemiology 12

Mark A. Miller

252 papers receiving 16.6k citations

Mark A. Miller's Hit Papers

Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809 2011 · 842 citations
8420+7+14Years since publication50010001.5k

Peers

Mark A. Miller
Comparison fields: 5 of 192
  • Infectious Diseases 6.8k
  • Modeling and Simulation 1.2k
  • Epidemiology 6.9k
  • Virology 658
  • Critical Care and Intensive Care Medicine 569
Replace Paul K.S. Chan with:
Paul K.S. Chan Hong Kong
Allison McGeer Canada
Yi‐Wei Tang United States
Vincent Chi‐Chung Cheng Hong Kong
Nicola Principi Italy
Patrick C. Y. Woo Hong Kong
Robert H. Gilman United States
Tim Peto United Kingdom
Walter A. Orenstein United States
Allen Cheng Australia
Mark A. Miller relative to Paul K.S. Chan Hong Kong Paul K.S. Chan's profile →
Citations per field
00.5×4.0×
Paul K.S. Chan · 1×
Citations per year

Countries citing papers authored by Mark A. Miller

Since Specialization
Citations

This map shows the geographic impact of Mark A. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Miller more than expected).

Fields of papers citing papers by Mark A. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Miller. The network helps show where Mark A. Miller may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Miller Line = papers co-authored together Mark A. Miller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
Hit paper breakdown →
20051565
2
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Hit paper breakdown →
20111160
3
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Hit paper breakdown →
2011842
4
Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza
Hit paper breakdown →
2009534
5 2005424
6
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
Hit paper breakdown →
2006412
7 2010393
8 2008350
9 1989341
10 2013298
11 2009254
12 2009236
13 2007233
14 1996207
15 2012198
16 2011194
17 1996184
18 2007181
19 2011181
20 2011169

About Mark A. Miller

Mark A. Miller is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Microbiology and Immunology, having authored 252 papers that have together received 17.2k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (47 papers), Clostridium difficile and Clostridium perfringens research (45 papers), COVID-19 epidemiological studies (18 papers), Respiratory viral infections research (13 papers), Antimicrobial Resistance in Staphylococcus (13 papers), Bacillus and Francisella bacterial research (12 papers), Viral gastroenteritis research and epidemiology (12 papers) and Bacterial Infections and Vaccines (12 papers). The work is most often cited by research in Infectious Diseases (6.8k citations), Modeling and Simulation (1.2k citations), Epidemiology (6.9k citations), Virology (658 citations) and Critical Care and Intensive Care Medicine (569 citations). Mark A. Miller has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Cécile Viboud, Lone Simonsen, Thomas Louie, Kathleen M. Mullane, Gerardo Chowell, Sherwood L. Gorbach, André Dascal, Wladimir J. Alonso, Arnold Lentnek and Yoav Golan. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology, PLoS ONE, Infection Control and Hospital Epidemiology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact